Bide Pharmatech Co., Ltd. (SHA:688073)

Bide Pharmatech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,086	4,342	5,044	5,333	-	-
Market Cap Growth	32.60%	-13.91%	-5.42%	-	-	-
Enterprise Value	3,777	3,260	3,905	3,860	-	-
Last Close Price	46.60	49.16	53.87	56.28	-	-
PE Ratio	34.00	36.98	46.03	36.53	-	-
Forward PE	29.13	31.74	22.50	30.12	-	-
PS Ratio	3.60	3.94	4.62	6.40	-	-
PB Ratio	2.01	2.14	2.41	2.57	-	-
P/TBV Ratio	2.01	2.15	2.42	2.57	-	-
P/FCF Ratio	134.91	62.06	-	-	-	-
P/OCF Ratio	34.85	27.43	-	178.53	-	-
EV/Sales Ratio	3.33	2.96	3.58	4.63	-	-
EV/EBITDA Ratio	23.80	26.38	35.88	25.71	-	-
EV/EBIT Ratio	29.06	28.92	39.33	26.74	-	-
EV/FCF Ratio	124.71	46.59	-	-	-	-
Debt / Equity Ratio	0.15	0.04	0.03	0.02	0.04	0.05
Debt / EBITDA Ratio	1.89	0.58	0.45	0.25	0.23	0.22
Debt / FCF Ratio	9.91	1.18	-	-	-	-
Asset Turnover	0.45	0.46	0.46	0.51	0.86	1.01
Inventory Turnover	0.93	0.93	1.10	0.94	0.91	1.07
Quick Ratio	1.48	4.12	5.54	6.84	1.31	1.59
Current Ratio	2.88	6.39	8.22	9.01	3.28	3.19
Return on Equity (ROE)	5.99%	5.71%	5.21%	10.79%	19.65%	23.58%
Return on Assets (ROA)	3.22%	2.92%	2.60%	5.53%	9.51%	12.30%
Return on Capital (ROIC)	3.64%	3.31%	2.91%	6.50%	12.96%	17.53%
Return on Capital Employed (ROCE)	6.30%	5.40%	4.60%	6.80%	16.40%	20.90%
Earnings Yield	2.99%	2.70%	2.17%	2.74%	-	-
FCF Yield	0.74%	1.61%	-2.35%	-0.16%	-	-
Dividend Yield	1.98%	1.83%	1.67%	1.96%	-	-
Payout Ratio	66.83%	68.03%	91.29%	0.06%	0.19%	42.22%
Buyback Yield / Dilution	1.62%	1.76%	-22.83%	-10.09%	-8.03%	-610.24%
Total Shareholder Return	3.68%	3.59%	-21.16%	-8.14%	-8.03%	-610.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.